SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001485003-19-000025
Filing Date
2019-04-30
Accepted
2019-04-30 16:18:44
Documents
4
Period of Report
2019-06-19
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A sesn2019proxystatementstoc.htm DEF 14A 700187
2 logoa01.jpg GRAPHIC 7341
3 tom2a02.jpg GRAPHIC 82342
4 tom2a03.jpg GRAPHIC 82342
  Complete submission text file 0001485003-19-000025.txt   927502
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36296 | Film No.: 19782011
SIC: 2834 Pharmaceutical Preparations